Brice Curtin

Scientist I – Medicinal Chemist at Dicerna Pharmaceuticals - Lexington, MA, US

Brice Curtin's Colleagues at Dicerna Pharmaceuticals
Ken DiCienzo

Corporate Communications Specialist

Contact Ken DiCienzo

Sean Lacey

Senior Manager, Statistical Programming

Contact Sean Lacey

Shawna Roche

Senior Manager, Procurement Operations

Contact Shawna Roche

Marjon Bree

Associate Scientist I

Contact Marjon Bree

Peter DiStefano

Scientist II, Discovery Research

Contact Peter DiStefano

Kelli Bracken

Quality Training Specialist

Contact Kelli Bracken

Marjorie Prophete

Clinical Documentation Manager

Contact Marjorie Prophete

View All Brice Curtin's Colleagues
Brice Curtin's Contact Details
HQ
617-621-8097
Location
Cambridge, Massachusetts, United States
Company
Dicerna Pharmaceuticals
Brice Curtin's Company Details
Dicerna Pharmaceuticals logo, Dicerna Pharmaceuticals contact details

Dicerna Pharmaceuticals

Lexington, MA, US • 500 - 999 Employees
Major Drugs

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Using our proprietary GalXC™ and GalXC-Plus™ RNAi technologies, we discover and develop innovative RNAi-based therapies with the potential to treat both rare and more prevalent diseases. By silencing disease-causing genes, our GalXC platform has the potential to address conditions that are difficult to treat with other modalities. Initially focused on disease-causing genes in the liver, we have continued to innovate and are exploring new applications of our RNAi technology with GalXC-Plus, which expands on the functionality and application of our flagship liver-targeted GalXC technology to tissues and cell types outside the liver with the potential to treat diseases across multiple therapeutic areas. Our team brings together talented experts across the fields of biology, chemistry, clinical science, medicine and more. With decades of scientific and technical experience focused on RNAi technology, we have the knowledge and experience needed to discover and develop therapies for patients with serious unmet medical needs. Between our own pipeline of core discovery and clinical candidates and those developed through collaborative relationships with some of the world's leading pharmaceutical companies, we have generated more than 20 active discovery, preclinical or clinical proprietary and collaborative programs focused on rare, cardiometabolic, viral, chronic liver and complement-mediated diseases, as well as neurodegenerative diseases and pain.

B2B Biotechnology Healthcare Pharmaceuticals Major Drugs Pharmaceutical Preparations Biotech Pharmaceuticals
Details about Dicerna Pharmaceuticals
Frequently Asked Questions about Brice Curtin
Brice Curtin currently works for Dicerna Pharmaceuticals.
Brice Curtin's role at Dicerna Pharmaceuticals is Scientist I – Medicinal Chemist.
Brice Curtin's email address is ***@dicerna.com. To view Brice Curtin's full email address, please signup to ConnectPlex.
Brice Curtin works in the Major Drugs industry.
Brice Curtin's colleagues at Dicerna Pharmaceuticals are Ken DiCienzo, Sean Lacey, Shawna Roche, Marjon Bree, Peter DiStefano, Kelli Bracken, Marjorie Prophete and others.
Brice Curtin's phone number is 617-621-8097
See more information about Brice Curtin